BIOLASE Correlations
| BIOL Stock | USD 0.17 0.01 5.56% |
The correlation of BIOLASE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BIOLASE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BIOLASE moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Very good diversification
The correlation between BIOLASE and NYA is -0.29 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BIOLASE and NYA in the same portfolio, assuming nothing else is changed.
BIOLASE |
The ability to find closely correlated positions to BIOLASE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BIOLASE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BIOLASE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BIOLASE to buy it.
Moving against BIOLASE Stock
| 0.58 | FBRX | Forte Biosciences Earnings Call This Week | PairCorr |
| 0.49 | ERAS | Erasca Inc Financial Report 20th of May 2024 | PairCorr |
| 0.49 | LLY | Eli Lilly | PairCorr |
| 0.44 | NAMSW | NewAmsterdam Pharma | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between BIOLASE Stock performing well and BIOLASE Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BIOLASE's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BBLG | 4.87 | (0.50) | 0.00 | 9.67 | 0.00 | 8.70 | 58.44 | |||
| BJDX | 3.55 | (0.75) | 0.00 | (0.19) | 0.00 | 8.06 | 30.43 | |||
| TLIS | 1.78 | 0.36 | 0.15 | 0.64 | 1.84 | 5.00 | 14.70 | |||
| NUWE | 8.24 | 0.09 | 0.00 | 0.38 | 10.40 | 16.67 | 75.82 | |||
| HSCS | 3.75 | (0.26) | 0.00 | 0.50 | 0.00 | 10.00 | 66.24 | |||
| TIVC | 5.00 | (0.60) | 0.00 | (0.98) | 0.00 | 9.45 | 53.24 | |||
| NAOV | 3.03 | (0.30) | 0.00 | (0.40) | 0.00 | 6.67 | 20.57 | |||
| VVOS | 3.78 | (1.36) | 0.00 | (0.61) | 0.00 | 5.69 | 41.96 | |||
| BVS | 2.92 | 0.38 | 0.09 | (1.58) | 2.80 | 6.98 | 29.56 | |||
| ASXC | 3.07 | 0.17 | 0.01 | (0.27) | 3.21 | 6.90 | 40.48 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in BIOLASE without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
BIOLASE Corporate Management
Elected by the shareholders, the BIOLASE's board of directors comprises two types of representatives: BIOLASE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BIOLASE. The board's role is to monitor BIOLASE's management team and ensure that shareholders' interests are well served. BIOLASE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BIOLASE's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Rodriguez | Director Events | Profile | |
| Jennifer Bright | Chief Officer | Profile | |
| Russell DDS | Chief Officer | Profile | |
| Michael Carroll | Corporate Secretary | Profile | |
| Steven Sandor | Chief Officer | Profile |
Already Invested in BIOLASE?
The danger of trading BIOLASE is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BIOLASE is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BIOLASE. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile BIOLASE is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether BIOLASE is a strong investment it is important to analyze BIOLASE's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BIOLASE's future performance. For an informed investment choice regarding BIOLASE Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIOLASE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for BIOLASE Stock analysis
When running BIOLASE's price analysis, check to measure BIOLASE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIOLASE is operating at the current time. Most of BIOLASE's value examination focuses on studying past and present price action to predict the probability of BIOLASE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIOLASE's price. Additionally, you may evaluate how the addition of BIOLASE to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stocks Directory Find actively traded stocks across global markets |
Is BIOLASE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIOLASE. If investors know BIOLASE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIOLASE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (29.44) | Revenue Per Share 38.469 | Quarterly Revenue Growth (0.04) | Return On Assets (0.29) | Return On Equity (6.03) |
The market value of BIOLASE is measured differently than its book value, which is the value of BIOLASE that is recorded on the company's balance sheet. Investors also form their own opinion of BIOLASE's value that differs from its market value or its book value, called intrinsic value, which is BIOLASE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIOLASE's market value can be influenced by many factors that don't directly affect BIOLASE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIOLASE's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIOLASE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIOLASE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.